Skip to search formSkip to main contentSkip to account menu

brodimoprim

Known as: 2,4-diamino-5-(4-bromo-3,5-dimethoxybenzyl)pyrimidine 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
The isolation and physicochemical characterization of four crystalline modifications of brodimoprim (5-[(4-bromo-3,5… 
1999
1999
1H and 15N NMR studies have been undertaken on complexes of Lactobacillus casei dihydrofolate reductase (DHFR) formed with… 
1995
1995
Two-dimensional (2D) double-quantum-filtered correlation spectroscopy (DQF-COSY), total correlation spectroscopy (TOCSY), nuclear… 
Review
1993
Review
1993
Brodimoprim is a new 2,4-diaminobenzylpyrimidine that selectively inhibits bacterial and resistance plasmid dihydrofolate… 
1993
1993
Brodimoprim was studied in the treatment of acute respiratory tract infections in hospitalized, basically healthy, military… 
1991
1991
A new dihydrofolate inhibitor, brodimoprim, was compared with amoxicillin in the treatment of acute sinusitis in a general… 
1984
1984
A consideration of the detailed structural information available from X-ray crystallographic and NMR studies on complexes of… 
1984
1984
Based on both IC50 and Ki values, brodimoprim (BDP) was often found to be two- to threefold more effective than trimethoprim (TMP…